Clinic
J. C. Blair Memorial Hospital
J. C. Blair Memorial Hospital was paid $2.25M by Medicaid between Jan 2018 and Dec 2024, across 154 billing codes. Its largest line is T1015, a visit at a community health center or clinic (one all-in rate) — 18% of everything it billed.
33Billing provider infoJ. C. BLAIR MEMORIAL HOSPITAL
HUNTINGDON, PA 16652
HUNTINGDON, PA 16652
33aNPI1700878840assigned 08/16/2005
33bProvider typeClinic/Center
28Total paid$2.25M
24GClaims86,301
24DCodes billed154
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Clinic/Center providers in Pennsylvania
Rank by total paid#51 of 176
Median peer was paid$441K
This provider vs. median5.1×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 209 | $1K | |
| 2019 | 97 | $690.24 | |
| 2020 | 10,494 | $162K | |
| 2021 | 40,561 | $836K | |
| 2022 | 7,874 | $276K | |
| 2023 | 12,467 | $457K | |
| 2024incomplete | 14,599 | $513K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| T1015 | A visit at a community health center or clinic (one all-in rate)Clinic visit/encounter, all-inclusive | 18% | 8,013 | 6,010 | $406K |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 17% | 6,326 | 6,054 | $392K |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 17% | 4,229 | 3,985 | $390K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 5.5% | 1,094 | 1,049 | $124K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 4.3% | 1,209 | 1,190 | $96K |
| G0378 | Hospital observation service, per hour | 3.3% | 139 | 126 | $75K |
| 80053 | Comprehensive metabolic panel | 2.9% | 7,001 | 6,540 | $64K |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | 2.4% | 2,055 | 2,005 | $53K |
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r | 2.2% | 606 | 595 | $50K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 1.9% | 278 | 272 | $42K |
| 80050 | General health panel | 1.8% | 885 | 870 | $40K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 1.6% | 7,523 | 6,806 | $35K |
142 more codes
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 1.3% | 1,263 | $28K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 1.1% | 512 | $24K |
| 80061 | Lipid panel | 1.0% | 1,841 | $23K |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | 1.0% | 255 | $23K |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 407 | $19K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 1,034 | $19K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 251 | $18K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 2,186 | $17K |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 111 | $16K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 207 | $16K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 543 | $15K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 573 | $15K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 264 | $15K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 1,079 | $14K |
| 84484 | <1% | 1,470 | $11K | |
| 87070 | <1% | 1,537 | $10K | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 618 | $9K |
| 84703 | <1% | 725 | $7K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 1,109 | $7K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 768 | $7K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 1,080 | $7K |
| 83880 | <1% | 310 | $6K | |
| 71045 | Radiologic examination, chest; single view | <1% | 1,113 | $6K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 596 | $6K |
| 83735 | <1% | 1,104 | $6K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 745 | $5K |
| 81001 | <1% | 2,084 | $5K | |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 168 | $5K |
| 0002A | <1% | 155 | $4K | |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 207 | $4K |
| 83690 | <1% | 1,081 | $4K | |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 267 | $4K |
| 0001A | <1% | 199 | $4K | |
| 82607 | <1% | 340 | $4K | |
| 84439 | <1% | 517 | $4K | |
| 73610 | <1% | 209 | $3K | |
| 86618 | <1% | 148 | $3K | |
| 85027 | <1% | 589 | $3K | |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | <1% | 329 | $3K |
| 93017 | <1% | 109 | $3K | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 135 | $3K |
| 82728 | <1% | 267 | $3K | |
| 73630 | <1% | 295 | $3K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 4,848 | $3K |
| 73030 | <1% | 196 | $2K | |
| 85610 | <1% | 836 | $2K | |
| 87186 | <1% | 388 | $2K | |
| 87631 | <1% | 17 | $2K | |
| 83540 | <1% | 324 | $2K | |
| 71250 | <1% | 55 | $2K | |
| 85380 | <1% | 299 | $2K | |
| 84702 | <1% | 118 | $2K | |
| 87088 | <1% | 296 | $2K | |
| 85730 | <1% | 407 | $2K | |
| 74019 | <1% | 138 | $2K | |
| 72100 | <1% | 116 | $2K | |
| 82550 | <1% | 352 | $2K | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 504 | $2K |
| 82043 | <1% | 226 | $2K | |
| 83605 | <1% | 272 | $2K | |
| 81003 | <1% | 631 | $2K | |
| 96376 | <1% | 102 | $1K | |
| 73110 | <1% | 141 | $1K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 210 | $1K |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 30 | $1K |
| 87077 | <1% | 211 | $1K | |
| 85652 | <1% | 497 | $1K | |
| 87081 | <1% | 185 | $1K | |
| 73130 | <1% | 100 | $1K | |
| 76830 | Ultrasound, transvaginal | <1% | 27 | $1K |
| 87040 | <1% | 95 | $980.64 | |
| 74018 | <1% | 79 | $918.98 | |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 77 | $841.05 |
| 87493 | <1% | 25 | $788.28 | |
| 83550 | <1% | 190 | $787.67 | |
| 80320 | <1% | 69 | $773.30 | |
| 88342 | <1% | 14 | $769.20 | |
| 73562 | <1% | 49 | $711.80 | |
| 86140 | <1% | 332 | $704.69 | |
| 82150 | <1% | 155 | $633.00 | |
| 94729 | <1% | 27 | $607.81 | |
| 80076 | <1% | 71 | $577.14 | |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 13 | $559.00 |
| 86617 | <1% | 12 | $509.32 | |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | <1% | 14 | $469.42 |
| 84436 | <1% | 54 | $459.98 | |
| 94060 | <1% | 52 | $448.02 | |
| 76536 | <1% | 12 | $442.54 | |
| 76642 | <1% | 13 | $441.12 | |
| 73564 | <1% | 27 | $415.54 | |
| 94727 | <1% | 26 | $402.12 | |
| 93226 | <1% | 15 | $393.66 | |
| 82248 | <1% | 55 | $378.39 | |
| 82553 | <1% | 56 | $365.17 | |
| 99213 | Doctor's office visit, returning patient (routine) | <1% | 428 | $334.20 |
| 84153 | <1% | 12 | $319.16 | |
| 92567 | <1% | 30 | $290.40 | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 12 | $268.39 |
| 92557 | <1% | 13 | $255.20 | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 12 | $250.46 |
| 86803 | <1% | 12 | $243.20 | |
| 86038 | <1% | 18 | $243.00 | |
| 87428 | <1% | 27 | $238.30 | |
| 87015 | <1% | 28 | $188.25 | |
| 73080 | <1% | 17 | $187.45 | |
| 93225 | <1% | 15 | $180.72 | |
| J2704 | Injection, propofol, 10 mg | <1% | 242 | $177.65 |
| 84100 | <1% | 30 | $128.46 | |
| 86431 | <1% | 17 | $125.19 | |
| 87329 | <1% | 12 | $105.86 | |
| 73090 | <1% | 12 | $98.90 | |
| 87899 | <1% | 17 | $97.60 | |
| 81025 | <1% | 30 | $93.14 | |
| 87045 | <1% | 16 | $89.70 | |
| A6231 | Gauze, impregnated, hydrogel, for direct wound contact, sterile, pad size 16 sq. in. or less, each dressing | <1% | 252 | $81.60 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 900 | $71.84 |
| 84550 | <1% | 12 | $60.50 | |
| 86901 | <1% | 15 | $48.81 | |
| 86900 | <1% | 15 | $48.19 | |
| 86592 | <1% | 13 | $48.00 | |
| 89055 | <1% | 12 | $41.52 | |
| 87046 | <1% | 16 | $33.92 | |
| 83615 | <1% | 19 | $30.92 | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 77 | $28.60 |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | <1% | 73 | $23.77 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 424 | $22.95 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 33 | $17.92 |
| 82140 | <1% | 13 | $11.93 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 39 | $11.70 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 45 | $9.98 |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 15 | $4.36 |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | <1% | 13 | $1.00 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 13 | $0.24 |
| 3075F | 0% | 113 | $0.00 | |
| 3079F | 0% | 358 | $0.00 | |
| A9270 | Non-covered item or service | 0% | 58 | $0.00 |
| 3074F | 0% | 558 | $0.00 | |
| G8510 | Screening for depression is documented as negative, a follow-up plan is not required | 0% | 112 | $0.00 |
| 3080F | 0% | 87 | $0.00 | |
| J7030 | Infusion, normal saline solution , 1000 cc | 0% | 351 | $0.00 |
| 3077F | 0% | 87 | $0.00 | |
| 3078F | 0% | 362 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialMYERS, JOSEPH (CEO)
Parent organizationPENN HIGHLANDS HEALTHCARE
| Provider | Location | Paid |
|---|---|---|
| Nursing on Demand INC | Jacksonville, FL | $891K |
| J C Blair Medical Services INC | Huntingdon, PA | $287K |
| Joseph W Myers Od INC | Moundsville, WV | $168K |
| J C Blair Memorial Hospital | Huntingdon, PA | $43K |
| J C Blair Memorial Hospital | Huntingdon, PA | $13K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.